These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 37576246)
1. Study on the function of Huazhuo Jiedu Decoction in promoting the homing of bone marrow mesenchymal stem cells and contributing to the treatment of ulcerative colitis. Ma Y; Li Y; Zhang S; Liu Z; Du L; Zhang X; Jia X; Yang Q Heliyon; 2023 Aug; 9(8):e18802. PubMed ID: 37576246 [TBL] [Abstract][Full Text] [Related]
2. Shenling Baizhu Decoction treats ulcerative colitis of spleen-deficiency and dampness obstruction types by targeting 'gut microbiota and galactose metabolism-bone marrow' axis. Li Y; Zhu Z; He S; Tang J; Zhang Y; Yang Y; Dong Y; He L; Jia Y; Liu X J Ethnopharmacol; 2024 Dec; 335():118599. PubMed ID: 39043352 [TBL] [Abstract][Full Text] [Related]
3. BMSC cells alleviate liver injury induced by ulcerative colitis via repairing the intestinal-liver barrier and activating hepatocyte growth factor. Deng Z; Meng Y; Zhao L; Luo W; Zhang J; Hu J; Jiang H; Zhang Q Cell Mol Biol (Noisy-le-grand); 2023 Feb; 69(2):19-25. PubMed ID: 37224050 [TBL] [Abstract][Full Text] [Related]
4. Dahuang Mudan decoction repairs intestinal barrier in chronic colitic mice by regulating the function of ILC3. Huang S; Wang X; Xie X; Su Y; Pan Z; Li Y; Liang J; Zhang M; Pan S; Xu B; Li L; Chen J; Luo X; Zhou L J Ethnopharmacol; 2022 Dec; 299():115652. PubMed ID: 36038092 [TBL] [Abstract][Full Text] [Related]
5. Pulsatilla decoction improves DSS-induced colitis via modulation of fecal-bacteria-related short-chain fatty acids and intestinal barrier integrity. Niu C; Hu XL; Yuan ZW; Xiao Y; Ji P; Wei YM; Hua YL J Ethnopharmacol; 2023 Jan; 300():115741. PubMed ID: 36162543 [TBL] [Abstract][Full Text] [Related]
6. [Jiawei Baitouweng Decoction affects intestinal mucosal tight junction proteins in rats with ulcerative colitis through p38 MAPK-MLCK signaling pathway]. Zhang PP; Yang X; Liang GQ; Zhu HP; Zhu H; Wang M; Sun HW Zhongguo Zhong Yao Za Zhi; 2021 Nov; 46(21):5719-5726. PubMed ID: 34951226 [TBL] [Abstract][Full Text] [Related]
7. Modified Gegen Qinlian decoction ameliorated ulcerative colitis by attenuating inflammation and oxidative stress and enhancing intestinal barrier function in vivo and in vitro. Wang Y; Zhang J; Zhang B; Lu M; Ma J; Liu Z; Huang J; Ma J; Yang X; Wang F; Tang X J Ethnopharmacol; 2023 Sep; 313():116538. PubMed ID: 37086872 [TBL] [Abstract][Full Text] [Related]
8. Gegen Qinlian decoction activates AhR/IL-22 to repair intestinal barrier by modulating gut microbiota-related tryptophan metabolism in ulcerative colitis mice. Wang X; Huang S; Zhang M; Su Y; Pan Z; Liang J; Xie X; Wang Q; Chen J; Zhou L; Luo X J Ethnopharmacol; 2023 Feb; 302(Pt B):115919. PubMed ID: 36356716 [TBL] [Abstract][Full Text] [Related]
9. Extracellular vesicles derived from EphB2-overexpressing bone marrow mesenchymal stem cells ameliorate DSS-induced colitis by modulating immune balance. Yu T; Chu S; Liu X; Li J; Chen Q; Xu M; Wu H; Li M; Dong Y; Zhu F; Zhou H; Hu D; Fan H Stem Cell Res Ther; 2021 Mar; 12(1):181. PubMed ID: 33722292 [TBL] [Abstract][Full Text] [Related]
10. Huangqin Decoction Attenuates DSS-Induced Mucosal Damage and Promotes Epithelial Repair via Inhibiting TNF-α-Induced NF-κB Activation. Gu LM; Li H; Xia JQ; Pan CY; Gu C; Tian YZ Chin J Integr Med; 2022 Feb; 28(2):124-129. PubMed ID: 34874516 [TBL] [Abstract][Full Text] [Related]
11. [Anti-inflammatory effect, plasma effective components and therapeutic targets of Huanglian Jiedu Decoction on ulcerative colitis mice]. Cui XJ; Lu Z; Xiao SM; Fang XW; Wen YL; Xiong WN; Yu K; Liang JQ Zhongguo Zhong Yao Za Zhi; 2021 Jan; 46(1):206-213. PubMed ID: 33645072 [TBL] [Abstract][Full Text] [Related]
12. [Effect of total triterpenoids of Chaenomeles speciosa on PPARγ/SIRT1/NF-κBp65 signaling pathway and intestinal mucosal barrier of ulcerative colitis induced by DSS in mice]. Xiong XJ; Li XM; He YM; Li XQ; Xu HY; Feng ML; He HB; Zhang JH; Zhu S; Komatsu Katsuko ; Zou K Zhongguo Zhong Yao Za Zhi; 2018 Nov; 43(21):4295-4304. PubMed ID: 30583632 [TBL] [Abstract][Full Text] [Related]
13. Effect of toll-like receptor 3 agonist poly I:C on intestinal mucosa and epithelial barrier function in mouse models of acute colitis. Zhao HW; Yue YH; Han H; Chen XL; Lu YG; Zheng JM; Hou HT; Lang XM; He LL; Hu QL; Dun ZQ World J Gastroenterol; 2017 Feb; 23(6):999-1009. PubMed ID: 28246473 [TBL] [Abstract][Full Text] [Related]
14. Bone marrow mesenchymal stem cells combined with Zheng Z; Wang J Bioengineered; 2022 Jan; 13(1):824-833. PubMed ID: 34898358 [TBL] [Abstract][Full Text] [Related]
15. Benefit Effect of Zheng X; Xiong TX; Zhang K; Zhou FC; Wang HY; Li B; Dong YJ; He X; Li LZ; Yu QX; Lv GY; Chen SH Evid Based Complement Alternat Med; 2021; 2021():9658638. PubMed ID: 35003313 [TBL] [Abstract][Full Text] [Related]
16. Pretreating mesenchymal stem cells with IL-6 regulates the inflammatory response of DSS-induced ulcerative colitis in rats. Ding Q; Fang H; Jin P; Lv J; Ding S; Zhu W; Chen C Transpl Immunol; 2023 Feb; 76():101765. PubMed ID: 36462558 [TBL] [Abstract][Full Text] [Related]
17. Huanglian Jiedu Decoction ameliorates DSS-induced colitis in mice via the JAK2/STAT3 signalling pathway. Lu Z; Xiong W; Xiao S; Lin Y; Yu K; Yue G; Liu Q; Li F; Liang J Chin Med; 2020; 15():45. PubMed ID: 32411291 [TBL] [Abstract][Full Text] [Related]
18. [Study of immuno-tolerance mechanism of the third-party bone marrow-derived mesenchymal stem cells in allogenic transplantation]. Qi BD; Meng BX; Yang Y; Liu B; Li CC; Xia W; Guo SZ; Zhang C Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 May; 27(3):207-12. PubMed ID: 21838003 [TBL] [Abstract][Full Text] [Related]
19. Effects and Mechanism of Constitutive TL1A Expression on Intestinal Mucosal Barrier in DSS-Induced Colitis. Yang M; Jia W; Wang D; Han F; Niu W; Zhang H; Shih DQ; Zhang X Dig Dis Sci; 2019 Jul; 64(7):1844-1856. PubMed ID: 30949903 [TBL] [Abstract][Full Text] [Related]
20. Ganluyin ameliorates DSS-induced ulcerative colitis by inhibiting the enteric-origin LPS/TLR4/NF-κB pathway. Xiong T; Zheng X; Zhang K; Wu H; Dong Y; Zhou F; Cheng B; Li L; Xu W; Su J; Huang J; Jiang Z; Li B; Zhang B; Lv G; Chen S J Ethnopharmacol; 2022 May; 289():115001. PubMed ID: 35085745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]